Clinical Trial Update: Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravenous azithromycin to eradicate Ureaplasma respiratory tract infection in preterm infants has completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureaplasma Infections in Preterm Infants

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Ureaplasma Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-05-17